FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

24581211000001105: Daclatasvir dihydrochloride (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 06-Jul 2022. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    79876801000001119 Daclatasvir dihydrochloride (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    79876901000001113 Daclatasvir dihydrochloride en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Daclatasvir dihydrochloride Is a Daclatasvir false Inferred relationship Existential restriction modifier
    Daclatasvir dihydrochloride Is a Daclatasvir false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Daclatasvir 30mg tablets Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daclatasvir 60mg tablets Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daclatasvir 60mg tablets 28 tablet Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daclatasvir 30mg tablets 28 tablet Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daklinza 60mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daclatasvir 90mg tablets Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daclatasvir 90mg tablets 28 tablet Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier
    Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Daclatasvir dihydrochloride Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start